Valuation
- Market cap
- 1,000
- Revenue TTM
- $0
- Net income TTM
- $-2,110,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- -0.37
Trading
- Volume
- 20,000
- Avg volume
- —
- Day's range
- $0.00 – $0.00
- Shares out
- 11,627,000
- Stochastic %K
- 50%
- Beta
- 12.19
- Analysts
- —
- Price target
- —
Company profile
Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson's disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge...
Show more
Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson's disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 919 518 3748
- Website
- https://adherathera.com
- Address
- 8000 Innovation Parkway, Baton Rouge, United States
Latest news
No headlines yet.
